PF-27546 |
DOLGENAL 60mg/2mL Solcucion Inyectable |
2007-05-13 |
|
Farmaceutica Paraguaya S.A. |
Paraguay
|
Asofarma, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-27711 |
LERTUS 75 mg/3mL. Solucion inyectable |
2007-05-27 |
|
Farmaceutica Paraguaya S.A. |
Paraguay
|
Asofarma, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-27735 |
DOLGENAL 10 mg. comprimidos recubiertos |
2007-05-27 |
|
Farmaceutica Paraguaya S.A. |
Paraguay
|
Asofarma, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-24354 |
ETOPOSIDO Farmaceutica Paraguaya 20 mg/1mL.Solucion inyectable |
2006-11-29 |
|
Farmaceutica Paraguaya S.A. |
Paraguay
|
Asofarma, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-24496 |
REGENTAL 10 mg. Solucion Inyectable |
2007-01-14 |
|
Farmaceutica Paraguaya S.A. |
Paraguay
|
Asofarma, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-24463 |
O-PLAT 100 mg. Liofilizado para uso parenteral |
2012-01-04 |
|
Farmaceutica Paraguaya S.A. |
Paraguay
|
Asofarma, S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-24878 |
MODIFICAL 8 mg Solución Inyectable |
2026-09-23 |
|
Farmaceutica Paraguaya S.A. |
Paraguay
|
J.I.Cohen, S.A. |
Agencias J. I. Cohen |
Asofarma |
DASA |
Equimed |
Droguería Y Farmacia Lanquetin |
Agefinsa |
Bodega Farmacéutica, S.A. |
Codister |
|
|
|
|
|
|
|
|
|
|
|
PF-24879 |
MODIFICAL 4 mg Comprimidos recubiertos |
2026-09-23 |
|
Farmaceutica Paraguaya S.A. |
Paraguay
|
J.I.Cohen, S.A. |
Agencias J.I. Cohen |
Asofarma |
Equimed |
Agefinsa |
Codister |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-24881 |
MODIFICAL 8 mg Comprimido recubierto |
2026-09-23 |
|
Farmaceutica Paraguaya S.A. |
Paraguay
|
J.I.Cohen, S.A. |
Agencias J. I. Cohen |
Asofarma |
DASA |
Equimed |
Droguería Y Farmacia Lanquetin |
Agefinsa |
Bodega Farmacéutica, S.A. |
Codister |
|
|
|
|
|
|
|
|
|
|
|
PF-24880 |
MODIFICAL 4 mg Solución Inyectable |
2026-09-23 |
|
Farmaceutica Paraguaya S.A. |
Paraguay
|
J.I.Cohen, S.A. |
Agencias J. I. Cohen |
Asofarma |
DASA |
Equimed |
Droguería Y Farmacia Lanquetin |
Agefinsa |
Bodega Farmacéutica, S.A. |
Codister |
|
|
|
|
|
|
|
|
|
|
|